PMVP 1.58 (-1.25%)
US69353Y1038BiotechnologyBiotechnology

PMV Pharmaceuticals (PMVP) Stock Highlights

1.58 | -1.25%
2024-10-21 05:16:26
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Statistics

Range Today
1.58 1.6
Volume Today 46.6K
Range 1 Year
1.17 3.47
Volume 1 Year 119.03M
Range 3 Year
1.17 25.85
Volume 3 Year 486.13M
Range 10 Year
1.17 63.22
Volume 10 Year 560.44M

Highlights

Market Capitalization 81.4M (small)
Floating Shares 38.42M
Current Price 1.58
Price To Earnings -1.67
Price To Book 0.38
Earnings Per Share -0.96
Payout Ratio 0%

Performance

Latest -1.25%
1 Month +3.95%
3 Months -1.86%
6 Months -3.66%
1 Year -18.97%
3 Years -93.39%
5 Years -95.49%
10 Years -95.49%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.